Total Payments
$1,631
2024 Payments
$312.86
Companies
16
Transactions
23
Medicare Patients
5,980
Medicare Billing
$330,512
Payment Breakdown by Category
Food & Beverage$1,584 (97.1%)
Other$47.45 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,584 | 22 | 97.1% |
| Entertainment | $47.45 | 1 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $242.77 | 2 | $0 (2024) |
| Allergan Inc. | $233.88 | 3 | $0 (2018) |
| Shire North American Group Inc | $174.89 | 2 | $0 (2018) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $139.40 | 2 | $0 (2018) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $116.14 | 1 | $0 (2019) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $109.69 | 1 | $0 (2017) |
| CooperVision Inc. | $93.19 | 1 | $0 (2024) |
| Spark Therapeutics, Inc. | $91.82 | 1 | $0 (2019) |
| Genentech USA, Inc. | $72.02 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $312.86 | 5 | ABBVIE INC. ($119.43) |
| 2022 | $183.21 | 4 | ABBVIE INC. ($123.34) |
| 2021 | $24.82 | 1 | Kala Pharmaceuticals, Inc. ($24.82) |
| 2019 | $255.41 | 3 | Aerie Pharmaceuticals, Inc. ($116.14) |
| 2018 | $629.64 | 7 | Shire North American Group Inc ($174.89) |
| 2017 | $225.24 | 3 | Allergan Inc. ($115.55) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | CooperVision Inc. | MiSight Contact Lens (Device) | Food and Beverage | In-kind items and services | $93.19 | General |
| Category: Devices | ||||||
| 10/31/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Ophthalmology | ||||||
| 10/12/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $119.43 | General |
| Category: EYE CARE | ||||||
| 03/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $67.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Ophthalmology | ||||||
| 06/28/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $123.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/08/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Ophthalmology | ||||||
| 02/02/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Ophthalmology | ||||||
| 08/13/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Ocular | ||||||
| 12/04/2019 | OPTOS, INC. | P200DTx (Device), P200T, P200TE | Entertainment | Cash or cash equivalent | $47.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/24/2019 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $91.82 | General |
| Category: OCULAR | ||||||
| 05/08/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $116.14 | General |
| Category: Glaucoma | ||||||
| 11/02/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $72.02 | General |
| Category: Ophthalmology | ||||||
| 10/23/2018 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $118.33 | General |
| 09/26/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $129.54 | General |
| Category: OPTHALMICS | ||||||
| 06/18/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BTOD (Device), ULTRA | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/23/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $113.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/17/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $45.35 | General |
| Category: OPTHALMICS | ||||||
| 01/30/2018 | GENZYME CORPORATION | CEREZYME (Drug), FABRAZYME, ALDURAZYME | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 06/28/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | SIMBRINZA (Biological) | Food and Beverage | In-kind items and services | $109.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/22/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $99.20 | General |
| 03/26/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $16.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,513 | 1,757 | $259,210 | $82,540 |
| 2022 | 10 | 1,580 | 1,786 | $240,595 | $83,172 |
| 2021 | 10 | 1,436 | 1,624 | $223,725 | $82,658 |
| 2020 | 9 | 1,451 | 1,602 | $218,035 | $82,141 |
Total Patients
5,980
Total Services
6,769
Medicare Billing
$330,512
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 422 | 433 | $83,445 | $32,431 | 38.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 247 | 386 | $54,970 | $22,340 | 40.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 148 | 188 | $22,560 | $7,066 | 31.3% |
| 92134 | Imaging of retina | Office | 2023 | 205 | 242 | $33,880 | $6,350 | 18.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 67 | 67 | $15,545 | $5,278 | 34.0% |
| 92250 | Photography of the retina | Office | 2023 | 150 | 155 | $21,700 | $3,691 | 17.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 144 | 150 | $21,000 | $3,082 | 14.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 104 | 104 | $4,160 | $1,991 | 47.9% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 12 | 18 | $1,530 | $210.84 | 13.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 14 | 14 | $420.00 | $101.40 | 24.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 420 | 428 | $70,620 | $31,919 | 45.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 262 | 394 | $49,250 | $22,276 | 45.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 160 | 183 | $21,960 | $7,241 | 33.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 73 | 73 | $14,235 | $6,126 | 43.0% |
| 92134 | Imaging of retina | Office | 2022 | 186 | 211 | $29,540 | $5,541 | 18.8% |
| 92250 | Photography of the retina | Office | 2022 | 183 | 192 | $26,880 | $4,488 | 16.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 149 | 151 | $21,140 | $3,209 | 15.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 103 | 103 | $4,120 | $1,863 | 45.2% |
| 67820 | Removal of eyelashes using forceps | Office | 2022 | 17 | 24 | $2,040 | $303.91 | 14.9% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 27 | 27 | $810.00 | $205.91 | 25.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 428 | 440 | $72,600 | $33,886 | 46.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 243 | 374 | $46,750 | $21,723 | 46.5% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 142 | 160 | $19,200 | $6,815 | 35.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 59 | 59 | $11,505 | $5,897 | 51.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 176 | 190 | $26,600 | $5,041 | 19.0% |
About Dr. Kamaljit Westfall, O.D
Dr. Kamaljit Westfall, O.D is a Optometrist healthcare provider based in Glens Falls, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376550749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kamaljit Westfall, O.D has received a total of $1,631 in payments from pharmaceutical and medical device companies, with $312.86 received in 2024. These payments were reported across 23 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,584).
As a Medicare-enrolled provider, Westfall has provided services to 5,980 Medicare beneficiaries, totaling 6,769 services with total Medicare billing of $330,512. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Other Specialties Corneal and Contact Management, Low Vision Rehabilitation
- Location Glens Falls, NY
- Active Since 08/01/2006
- Last Updated 01/06/2012
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1376550749
Products in Payments
- XIIDRA (Drug) $174.89
- VYZULTA (Drug) $131.92
- CEREZYME (Drug) $125.00
- VUITY (Drug) $123.34
- LUMIGAN (Drug) $119.43
- Rhopressa (Drug) $116.14
- SIMBRINZA (Biological) $109.69
- MiSight Contact Lens (Device) $93.19
- LUXTURNA (Biological) $91.82
- Lucentis (Biological) $72.02
- TEPEZZA (Biological) $67.50
- ARGOS (Device) $59.87
- P200DTx (Device) $47.45
- BTOD (Device) $26.04
- INVELTYS (Drug) $24.82
- XDEMVY (Drug) $14.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Glens Falls
Dr. Carolee Boyd, O.d, O.D
Optometrist — Payments: $4,427
Optometrist $4,427
Dr. Dawn Chivers, O.d, O.D
Optometrist — Payments: $3,853
Optometrist $3,853
Dr. Paul Westfall, O.d, O.D
Optometrist — Payments: $1,857
Optometrist $1,857
Dr. Enrique Yepes-Hoyos, Od, OD
Optometrist — Payments: $1,358
Optometrist $1,358
Dr. Jeffrey Jarett, Od, OD
Optometrist — Payments: $495.71
Optometrist $495.71
Dr. Terry Walton, O.d, O.D
Optometrist — Payments: $342.79
Optometrist $342.79